Medical Information

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

Not a healthcare professional? Go to the patient or caregiver website.

Updated Efficacy and Safety From the Phase 3 CROWN Study of First-Line Lorlatinib vs Crizotinib in Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

Solomon BJ, Bauer T, Mok T, Liu G, Mazieres J, de Marinis F, Goto Y, Kim D-W, Wu Y-L, Dvorkin M, Jassem J, López-López F, Soo R, Polli A, Dall'O' E, Iadeluca L, Toffalorio F, Felip E  April 12, 2022 AACR 2022 Lung Cancer